Negative Effects of the Inflation Reduction Act on the Life Sciences Manufacturing Industry
US Launches Attack on Drug Developers The Life Science Manufacturing industry has long been hailed as the bedrock of groundbreaking medical research and innovation, particularly in the realm of drug development. With the United States leading the charge, accounting for 55% of approved drugs globally, the mutualistic relationship between public and private sectors has undeniably […]